Results 291 to 300 of about 960,807 (326)
Some of the next articles are maybe not open access.
European Journal of Preventive Cardiology, 2023
BACKGROUND AND AIMS The synergistic association of remnant cholesterol (remnant-C) and low-density lipoprotein cholesterol (LDL-C) levels with incident cardiovascular disease (CVD) in various subgroups of Koreans was investigated.
Sang Jun Lee +13 more
semanticscholar +1 more source
BACKGROUND AND AIMS The synergistic association of remnant cholesterol (remnant-C) and low-density lipoprotein cholesterol (LDL-C) levels with incident cardiovascular disease (CVD) in various subgroups of Koreans was investigated.
Sang Jun Lee +13 more
semanticscholar +1 more source
Beyond lowering LDL cholesterol
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2011Compelling evidence from randomized controlled studies demonstrated the crucial role of lowering low-density lipoprotein cholesterol (LDL-C) in the prevention of vascular events. However, not all patients with low LDL-C levels show similar reduction in event rates.
Ozgür, Bayturan +2 more
openaire +2 more sources
Nature Reviews Cardiology, 2019
LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’.
Michael V. Holmes, Mika Ala-Korpela
openaire +3 more sources
LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’.
Michael V. Holmes, Mika Ala-Korpela
openaire +3 more sources
LDL cholesterol impairs therapy
Science Signaling, 2017A diet high in LDL cholesterol may hinder the therapeutic efficacy of tyrosine kinase inhibitors in cancer patients.
openaire +2 more sources
Beyond LDL Cholesterol Reduction
Circulation, 1996Within the past decade, clinical trials of LDL-C reduction have convincingly demonstrated that LDL-C reduction in primary and secondary prevention trials can significantly reduce clinical cardiac events.1 Arteriographic investigations have demonstrated that LDL-C reduction can significantly reduce the rate of arteriographically defined disease ...
openaire +2 more sources
Relationships between lymphocyte cholesterol homeostasis and LDL-cholesterol
Clinical Biochemistry, 1987The homeostasis of cholesterol was studied in lymphocytes freshly isolated from the blood and cultured with or without low-density lipoprotein (LDL). The content of cholesterol decreased in the lymphocytes cultured without LDL, whereas LDL substituted for cellular cholesterol losses, in spite of almost suppressed LDL-receptor and lymphocyte cholesterol
R, Hambitzer, I, Melzner, O, Haferkamp
openaire +2 more sources
LDL cholesterol hitches a ride
Science Translational Medicine, 2016A new lipid-binding protein transports low-density lipoprotein across the blood vessel endothelium and might promote atherosclerosis.
openaire +2 more sources